Seeking Alpha

  Celgene Corporation - NASDAQ

11/22/2014, 10:28 PM ET
  • The Scientist | Send Message 19 Aug 2012

    CELG Abraxane P3 panc ca studies likely to be a bust. Trial began 3/09; near end of trial 9/11, had to add 210 pts to the study
    Reply (2)
    • The Scientist | Send Message 19 Aug 2012
      : Only logical reason to add more pts was that OS data was weak; more pts were needed to raise OS data
    • The Scientist | Send Message 29 Aug 2012
      : SPARC recently shown to be beneficial in prostate CA pts.
      CELG vs. ETF Alternatives
      Company Description
      Celgene Corp is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States